Tocolytic therapy for preterm delivery: systematic review and network meta-analysis

Objective To determine the most effective tocolytic agent at delaying delivery. Design Systematic review and network meta-analysis. Data sources Cochrane Central Register of Controlled Trials, Medline, Medline In-Process, Embase, and CINAHL up to 17 February 2012. Study selection Randomised controlled trials of tocolytic therapy in women at risk of preterm delivery. Data extraction At least two reviewers extracted data on study design, characteristics, number of participants, and outcomes reported (neonatal and maternal). A network meta-analysis was done using a random effects model with drug class effect. Two sensitivity analyses were carried out for the primary outcome; restricted to studies at low risk of bias and restricted to studies excluding women at high risk of preterm delivery (those with multiple gestation and ruptured membranes). Results Of the 3263 titles initially identified, 95 randomized controlled trials of tocolytic therapy were reviewed. Compared with placebo, the probability of delivery being delayed by 48 hours was highest with prostaglandin inhibitors (odds ratio 5.39, 95% credible interval 2.14 to 12.34) followed by magnesium sulfate (2.76, 1.58 to 4.94), calcium channel blockers (2.71, 1.17 to 5.91), beta mimetics (2.41, 1.27 to 4.55), and the oxytocin receptor blocker atosiban (2.02, 1.10 to 3.80). No class of tocolytic was significantly superior to placebo in reducing neonatal respiratory distress syndrome. Compared with placebo, side effects requiring a change of medication were significantly higher for beta mimetics (22.68, 7.51 to 73.67), magnesium sulfate (8.15, 2.47 to 27.70), and calcium channel blockers (3.80, 1.02 to 16.92). Prostaglandin inhibitors and calcium channel blockers were the tocolytics with the best probability of being ranked in the top three medication classes for the outcomes of 48 hour delay in delivery, respiratory distress syndrome, neonatal mortality, and maternal side effects (all cause). Conclusions Prostaglandin inhibitors and calcium channel blockers had the highest probability of delaying delivery and improving neonatal and maternal outcomes.

[1]  S. Carlan,et al.  Rofecoxib Versus Magnesium Sulfate to Arrest Preterm Labor: A Randomized Trial , 2004, Obstetrics and gynecology.

[2]  R. Liston,et al.  Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: a multicenter effectiveness and safety study. , 2000, American journal of obstetrics and gynecology.

[3]  G. Saade,et al.  A randomized double-blind study comparing the fetal effects of sulindac to terbutaline during the management of preterm labor. , 1999, American Journal of Obstetrics and Gynecology.

[4]  H. Tamim,et al.  Terbutaline versus nifedipine for prolongation of pregnancy in patients with preterm labor. , 2008, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[5]  I. Merkatz,et al.  Ritodrine Hydrochloride: A Betamimetic Agent for Use in Preterm Labor. II. Evidence Of Efficacy , 1980, Obstetrics and gynecology.

[6]  Jonathan J Deeks,et al.  Much ado about nothing: a comparison of the performance of meta‐analytical methods with rare events , 2007, Statistics in medicine.

[7]  L. Doyle,et al.  Magnesium sulphate for preventing preterm birth in threatened preterm labour. , 2002, The Cochrane database of systematic reviews.

[8]  John P.A. Ioannidis,et al.  Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses , 2009, Canadian Medical Association Journal.

[9]  J. Morrison,et al.  Oral nicardipine versus intravenous magnesium sulfate for the treatment of preterm labor. , 1999, American journal of obstetrics and gynecology.

[10]  A. Jefferies,et al.  The effect of indomethacin tocolysis in preterm labour on perinatal outcome: a randomised placebo‐controlled trial , 1999, British journal of obstetrics and gynaecology.

[11]  G. Greisen,et al.  The effect of barusiban, a selective oxytocin antagonist, in threatened preterm labor at late gestational age: a randomized, double-blind, placebo-controlled trial. , 2009, American journal of obstetrics and gynecology.

[12]  I. Usta,et al.  Two dose regimens of nifedipine for management of preterm labor: a randomized controlled trial. , 2009, American journal of perinatology.

[13]  H. Gabert,et al.  A Prospective Comparison of Terbutaline and Magnesium for Tocolysis , 1992, Obstetrics and gynecology.

[14]  Arthur P. Dempster,et al.  The direct use of likelihood for significance testing , 1997, Stat. Comput..

[15]  A. Chittacharoen,et al.  Nifedipine versus terbutaline in management of preterm labor , 2002, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[16]  Yw Park,et al.  Multicentre, parallel group, randomised, single‐blind study of the safety and efficacy of atosiban versus ritodrine in the treatment of acute preterm labour in Korean women , 2006, BJOG : an international journal of obstetrics and gynaecology.

[17]  M. Keirse,et al.  Randomised comparison between a loading and incremental dose model for ritodrine administration in preterm labour , 1996, British journal of obstetrics and gynaecology.

[18]  G. Lu,et al.  Assessing Evidence Inconsistency in Mixed Treatment Comparisons , 2006 .

[19]  R. Petrie,et al.  A comparison of magnesium sulfate and alcohol for the prevention of premature labor. , 1977, American journal of obstetrics and gynecology.

[20]  G. Sullivan,et al.  The use of ritodrine and magnesium sulfate in the arrest of premature labor , 1984, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[21]  Roger Chou,et al.  Initial highly-active antiretroviral therapy with a protease inhibitor versus a non-nucleoside reverse transcriptase inhibitor: discrepancies between direct and indirect meta-analyses , 2006, The Lancet.

[22]  A. Mathur,et al.  A prospective randomized safety trial of celecoxib for treatment of preterm labor. , 2002, American journal of obstetrics and gynecology.

[23]  R. Tamura,et al.  Lack of effect of antenatal indomethacin on fetal cerebral blood flow. , 1997, American journal of obstetrics and gynecology.

[24]  K. Leveno,et al.  Randomized investigation of magnesium sulfate for prevention of preterm birth. , 1990, American journal of obstetrics and gynecology.

[25]  N. Fisk,et al.  A double-blind randomized study of fetal side effects during and after the short-term maternal administration of indomethacin, sulindac, and nimesulide for the treatment of preterm labor. , 2003, American journal of obstetrics and gynecology.

[26]  Deborah M Caldwell,et al.  Mixed treatment comparison analysis provides internally coherent treatment effect estimates based on overviews of reviews and can reveal inconsistency. , 2010, Journal of clinical epidemiology.

[27]  Nicky J Welton,et al.  Mixed treatment comparison of repeated measurements of a continuous endpoint: an example using topical treatments for primary open‐angle glaucoma and ocular hypertension , 2011, Statistics in medicine.

[28]  L. Ma.  [Magnesium sulfate in prevention of preterm labor]. , 1992, Zhonghua yi xue za zhi.

[29]  T. R. Johnson,et al.  Randomized comparative trial of indomethacin and ritodrine for the long-term treatment of preterm labor. , 1991, American journal of obstetrics and gynecology.

[30]  A. Omu,et al.  A Prospective Randomized Study Comparing Nifedipine versus Ritodrine for the Suppression of Preterm Labour , 2000, Medical Principles and Practice.

[31]  T. Goodwin,et al.  The effect of the oxytocin antagonist atosiban on preterm uterine activity in the human. , 1994, American journal of obstetrics and gynecology.

[32]  R. Berkowitz,et al.  Efficacy and side effects of magnesium sulfate and ritodrine as tocolytic agents. , 1988, American journal of obstetrics and gynecology.

[33]  M. Osler,et al.  Ritodrine in the treatment of preterm labour. A clinical trial to compare a standard treatment with three regimens involving the use of ritodrine. , 1980, British journal of obstetrics and gynaecology.

[34]  J. Neilson,et al.  Betamimetics for inhibiting preterm labour. , 2004, The Cochrane database of systematic reviews.

[35]  B. Schifrin,et al.  Comparison of magnesium sulfate, terbutaline and a placebo for inhibition of preterm labor. A randomized study. , 1984, The Journal of reproductive medicine.

[36]  M. Read,et al.  The use of a calcium antagonist (nifedipine) to suppress preterm labour , 1986, British journal of obstetrics and gynaecology.

[37]  Alexander J Sutton,et al.  What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. , 2004, Statistics in medicine.

[38]  G. S. Adam.  Isoxuprine and Premature Labour , 1966, The Australian & New Zealand journal of obstetrics & gynaecology.

[39]  J. Martin,et al.  Births: final data for 2007. , 2010, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[40]  J. Lessing,et al.  Nifedipine versus ritodrine for suppression of preterm labour , 1993, British journal of obstetrics and gynaecology.

[41]  R. Salamon,et al.  [A randomized study of the treatment of threatened premature labor. Nifedipine versus ritodrine]. , 1990, Journal de gynecologie, obstetrique et biologie de la reproduction.

[42]  R Lane,et al.  An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue. , 2000, American journal of obstetrics and gynecology.

[43]  T. McElrath.  Association between use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants. , 2003, American journal of obstetrics and gynecology.

[44]  A. Cipriani,et al.  Validity of indirect comparisons in meta-analysis , 2007, The Lancet.

[45]  J. Miller,et al.  A comparison of magnesium sulfate and terbutaline for the arrest of premature labor. A preliminary report. , 1982, The Journal of reproductive medicine.

[46]  D. Caldwell,et al.  Assessing the quality of evidence for preterm labor tocolytic trials , 2012, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[47]  M. Egger,et al.  The hazards of scoring the quality of clinical trials for meta-analysis. , 1999, JAMA.

[48]  G. Hankins,et al.  SINGLE-CENTRE RANDOMISED TRIAL OF RITODRINE HYDROCHLORIDE FOR PRETERM LABOUR , 1986, The Lancet.

[49]  M. Osler,et al.  RITODRINE IN THE TREATMENT OF PRETERM , 1980 .

[50]  J. Glock,et al.  Efficacy and safety of nifedipine versus magnesium sulfate in the management of preterm labor: a randomized study. , 1993, American journal of obstetrics and gynecology.

[51]  M. Kashanian,et al.  Comparison of the efficacy and adverse effects of nifedipine and indomethacin for the treatment of preterm labor , 2011, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[52]  I. Merkatz,et al.  Inhibition of premature labor: a multicenter comparison of ritodrine and ethanol. , 1977, American journal of obstetrics and gynecology.

[53]  R. Raymajhi,et al.  A comparative study between nifedipine and isoxsuprine in the suppression of preterm labour. , 2003, Kathmandu University medical journal.

[54]  P. Surichamorn.  The efficacy of terbutaline and magnesium sulfate in the management of preterm labor. , 2001, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[55]  Deborah M Caldwell,et al.  Simultaneous comparison of multiple treatments: combining direct and indirect evidence , 2005, BMJ : British Medical Journal.

[56]  J. Morrison,et al.  A comparative study of ketorolac (Toradol) and magnesium sulfate for arrest of preterm labor. , 1998 .

[57]  H. Brölmann,et al.  A randomized comparison of nifedipine and ritodrine for suppression of preterm labor. , 1998, European journal of obstetrics, gynecology, and reproductive biology.

[58]  R. White,et al.  The inhibition of premature labor with indomethacin. , 1980, American journal of obstetrics and gynecology.

[59]  D. Cabrol,et al.  Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol. , 2001, European journal of obstetrics, gynecology, and reproductive biology.

[60]  Anwar H Nassar,et al.  Magnesium sulfate compared with nifedipine for acute tocolysis of preterm labor: a randomized controlled trial. , 2007, Obstetrics and gynecology.

[61]  K. Maršál,et al.  The oxytocin antagonist atosiban versus the beta-agonist terbutaline in the treatment of preterm labor. A randomized, double-blind, controlled study. , 2001, Acta obstetricia et gynecologica Scandinavica.

[62]  R. Lamont.  Oxytocin receptor antagonists for inhibiting preterm labour. , 2008, Obstetrics and gynecology.

[63]  J. Morrison,et al.  A Comparative Study of Ketorolac (Toradol) and Magnesium Sulfate for Arrest of Preterm Labor , 1998, Southern medical journal.

[64]  D. Asch,et al.  Optimising maternal‐fetal outcomes in preterm labour: a decision analysis , 1998, British journal of obstetrics and gynaecology.

[65]  A. Kavishvar,et al.  Tocolytic efficacy of nifedipine versus ritodrine in preterm labor , 2007, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[66]  Miller Jm,et al.  A prospective comparison of terbutaline and magnesium for tocolysis. , 1992 .

[67]  Jiménez Jf,et al.  Tocolytic therapy with magnesium sulfate and terbutaline for inhibition of premature labor , 1990 .

[68]  P. Jouppila,et al.  Fetal cardiac function and ductus arteriosus during indomethacin and sulindac therapy for threatened preterm labor: a randomized study. , 1995, American journal of obstetrics and gynecology.

[69]  S. Caritis,et al.  A double-blind study comparing ritodrine and terbutaline in the treatment of preterm labor. , 1984, American journal of obstetrics and gynecology.

[70]  J. García-Velasco,et al.  A prospective, randomized trial of nifedipine vs. ritodrine in threatened preterm labor , 1998, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[71]  T. Imperiale,et al.  Tocolytic Therapy: A Meta-Analysis and Decision Analysis , 2009, Obstetrics and gynecology.

[72]  F. Saeidi,et al.  Celecoxib versus magnesium sulfate to arrest preterm labor: Randomized trial , 2007, The journal of obstetrics and gynaecology research.

[73]  G. Dekker,et al.  Calcium channel blockers for inhibiting preterm labour. , 2003, The Cochrane database of systematic reviews.

[74]  O. Ylikorkala,et al.  A Randomized Double-Dummy Comparison Between Indomethacin and Nylidrin in Threatened Preterm Labor , 1991, Obstetrics and gynecology.

[75]  H. Madhav,et al.  Efficacy and safety of indomethacin compared with magnesium sulfate in the management of preterm labor: a randomized study. , 1993, American journal of obstetrics and gynecology.

[76]  J. Geddes,et al.  Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis , 2009, The Lancet.

[77]  Bradley P. Carlin,et al.  Bayesian measures of model complexity and fit , 2002 .

[78]  T. Goodwin,et al.  Dose Ranging Study of the Oxytocin Antagonist Atosiban in the Treatment of Preterm Labor , 1996 .

[79]  N. Lorzadeh,et al.  A Comparison of Human Chorionic Gonadotropin with Magnesium Sulphate in Inhibition of Preterm Labor , 2007 .

[80]  W. Al-Omari,et al.  Atosiban and nifedipine in acute tocolysis: a comparative study. , 2006, European journal of obstetrics, gynecology, and reproductive biology.

[81]  Deborah M Caldwell,et al.  NICE DSU Technical Support Document 4: Inconsistency in Networks of Evidence Based on Randomised Controlled Trials. , 2011 .

[82]  A. Gargouri,et al.  Nicardipine versus salbutamol in the treatment of premature labor: comparison of their efficacy and side effects. , 2008, La Tunisie medicale.

[83]  L. Haghighi.  Prevention of preterm delivery: nifedipine or magnesium sulfate , 1999, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[84]  C. Ratanajamit,et al.  Safety and efficacy of oral nifedipine versus terbutaline injection in preterm labor. , 2007, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[85]  I. Usta,et al.  Randomized, double-blind, placebo-controlled trial of transdermal nitroglycerin for preterm labor. , 2007, American journal of obstetrics and gynecology.

[86]  J. King,et al.  Cyclo-oxygenase (COX) inhibitors for treating preterm labour. , 2005, The Cochrane database of systematic reviews.

[87]  S. Caritis.  Treatment of preterm labor with the beta-adrenergic agonist ritodrine. , 1992, The New England journal of medicine.

[88]  W. Spellacy,et al.  Treatment of premature labor with ritodrine: a randomized controlled study. , 1979, Obstetrics and gynecology.

[89]  M. Amorim,et al.  [Transdermal nitroglycerin versus oral nifedipine administration for tocolysis: a randomized clinical trial]. , 2009, Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia.

[90]  T. Lumley.  Network meta‐analysis for indirect treatment comparisons , 2002, Statistics in medicine.

[91]  K. Sekar,et al.  Treatment of patent ductus arteriosus: indomethacin or ibuprofen? , 2008, Journal of Perinatology.

[92]  B. Sibai,et al.  Tocolysis in women with preterm labor between 32 0/7 and 34 6/7 weeks of gestation: a randomized controlled pilot study. , 2006, American journal of obstetrics and gynecology.

[93]  M. Palacio,et al.  Nifedipine versus ritodrine for suppression of preterm labor. Comparison of their efficacy and secondary effects. , 2006, European journal of obstetrics, gynecology, and reproductive biology.

[94]  B. Zhu,et al.  [Treatment of preterm labor with ritodrine]. , 1996, Zhonghua fu chan ke za zhi.

[95]  Douglas G Altman,et al.  Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses , 2003, BMJ : British Medical Journal.

[96]  G. Lu,et al.  Combination of direct and indirect evidence in mixed treatment comparisons , 2004, Statistics in medicine.

[97]  G. Peckham,et al.  Clinical course to 1 year of age in premature infants with patent ductus arteriosus: results of a multicenter randomized trial of indomethacin. , 1984, The Journal of pediatrics.

[98]  Miller Jm,et al.  A comparison of magnesium sulfate and terbutaline for the arrest of premature labor. A preliminary report. , 1982 .

[99]  C. Weiner,et al.  The therapeutic efficacy and cost-effectiveness of aggressive tocolysis for premature labor associated with premature rupture of the membranes. , 1988, American journal of obstetrics and gynecology.

[100]  M. Kashanian,et al.  Atosiban and nifedipin for the treatment of preterm labor , 2005, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[101]  A E Ades,et al.  Meta‐analysis of mixed treatment comparisons at multiple follow‐up times , 2007, Statistics in medicine.

[102]  Michele Tarsilla.  Cochrane Handbook for Systematic Reviews of Interventions , 2010, Journal of MultiDisciplinary Evaluation.

[103]  J. Hauth,et al.  Intrauterine infection and preterm delivery. , 2000, The New England journal of medicine.

[104]  Taherian Ali Akbar,et al.  Comparison of efficacy and safety of nifedipine versus magnesium sulfate in treatment of preterm labor , 2007 .

[105]  P. Seed,et al.  TOCOX—A randomised, double‐blind, placebo‐controlled trial of rofecoxib (a COX‐2‐specific prostaglandin inhibitor) for the prevention of preterm delivery in women at high risk , 2005, BJOG : an international journal of obstetrics and gynaecology.

[106]  Sint Radboud Ziekenhuis.  A randomized trial of two beta-mimetic drugs for the treatment of threatening early labor Clinical results in a prospective comparative study with ritodrine and fenoterol , 1978 .

[107]  H. Jongsma,et al.  A randomized trial of two beta-mimetic drugs for the treatment of threatening early labor , 1978 .

[108]  R. Knuppel,et al.  Efficacy and safety of indomethacin versus ritodrine in the management of preterm labor; A randomized study , 1989, Obstetrics and gynecology.

[109]  G. Spearing.  Alcohol, Indomethacin, and Salbutamol: A Comparitive Trial of Their Use in Preterm Labor , 1979, Obstetrics and gynecology.

[110]  Chien-Nan Lee,et al.  Randomized trial of oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of spontaneous preterm labor in Taiwanese women. , 2009, Journal of the Formosan Medical Association = Taiwan yi zhi.

[111]  L. Marpeau,et al.  Nicardipine versus salbutamol in the treatment of premature labor. A prospective randomized study. , 1997, European journal of obstetrics, gynecology, and reproductive biology.

[112]  S. Oei,et al.  Tocolytic effectiveness of nifedipine versus ritodrine and follow‐up of newborns: a randomised controlled trial , 2008, Acta obstetricia et gynecologica Scandinavica.

[113]  J. Kuller,et al.  Neonatal complications after the administration of indomethacin for preterm labor , 1993, The New England journal of medicine.

[114]  M. Gummerus.  Tokolyse mit Hexoprenalin und Salbutamol im klinischen Vergleich* , 1983 .

[115]  H. Adèr,et al.  Nifedipine and Ritodrine in the Management of Preterm Labor: A Randomized Multicenter Trial , 1997, Obstetrics and gynecology.

[116]  D. Nagey,et al.  Magnesium sulfate and ritodrine hydrochloride: a randomized comparison. , 1987, American journal of obstetrics and gynecology.

[117]  G. Yeo,et al.  The Randomized Nitric Oxide Tocolysis Trial (RNOTT) for the treatment of preterm labor. , 2004, American journal of obstetrics and gynecology.

[118]  M. Gummerus.  [Tocolysis with hexoprenalin and salbutamol in a clinical comparison]. , 1983, Geburtshilfe und Frauenheilkunde.

[119]  R. Frydman,et al.  Atosiban versus usual care for the management of preterm labor , 2007, Journal of perinatal medicine.

[120]  B. Edgar,et al.  A comparison of ritodrine, terbutaline, and magnesium sulfate for the suppression of preterm labor. , 1985, American journal of obstetrics and gynecology.

[121]  P. Mital,et al.  Mefenamic Acid in Prevention of Premature Labour , 1992, Journal of the Royal Society of Health.

[122]  N. Welton,et al.  Addressing between‐study heterogeneity and inconsistency in mixed treatment comparisons: Application to stroke prevention treatments in individuals with non‐rheumatic atrial fibrillation , 2009, Statistics in medicine.

[123]  M. Zugaib,et al.  [Management of preterm labor]. , 2009, Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia.

[124]  E. Shalev,et al.  Further study of the inhibition of premature labor by indomethacin Part II double-blind study , 1984, Journal of perinatal medicine.

[125]  A. Csapo,et al.  Arrest of premature labor by isoxsuprine. , 1977, American journal of obstetrics and gynecology.

[126]  I. Ingemarsson.  Effect of terbutaline on premature labor. A double-blind placebo-controlled study. , 1976, American journal of obstetrics and gynecology.

[127]  F. Ghaffarpasand,et al.  Terbutaline versus salbutamol for suppression of preterm labor: a randomized clinical trial , 2010, Annals of Saudi medicine.